x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Global Neurology Academy

The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as

science & medicine medicine

All Episodes

00:00:00

Evolutions in Duchenne Muscular Dystrophy: Treatment...

Global Neurology Academy ·

2024/05/03

Host: Craig M. McDonald, MD Guest: Crystal Proud, MD Guest: Aravindhan Veerapandiyan, MD There are ongoing clinical trials and approvals for new genetic and non-genetic therapies for Duchenne muscular dystrophy. Determining the most suitable therapy for each patient is a developing process. This education covers dystrophin disruption and restoration, recent clinical trial outcomes from different treatment methods, and a case study exploring novel patient management

en

00:00:00

On the Clinic Floor: Addressing the Most Critical...

Global Neurology Academy ·

2024/04/25

Host: Robert Shin, MD, FANA, FAAN Guest: Enrique Alvarez, MD, PhD Guest: Jiwon Oh, MD, PhD, FRCPC The field of multiple sclerosis (MS) is evolving at a rapid pace from disease modifying therapies (DMTs) to diagnostic/monitoring tools to fundamental principles that shape how clinicians think about the disease. Though such advancements are welcome, they continue to raise new questions about how to optimize management for individual patients. In this program, real clinicians who

en

00:00:00

New Frontiers in Optimizing Patient Outcomes in...

Global Neurology Academy ·

2024/03/20

Host: Stephen Krieger, MD Guest: Tirisham Gyang, MD Guest: Augusto Miravalle, MD, FAAN New strategies for early intervention in multiple sclerosis (MS) are focusing on progression independent of relapse. These strategies include incorporation of high-efficacy disease modifying therapies in the early stages of MS coupled with effective management of treatment-related adverse events. Join Drs. Stephen Kreiger, Tirisham Gyang, and Augusto Miravalle for a lively, case-based

en

00:00:00

ABC-ICH: Does Care Bundling Improve Outcomes for...

Global Neurology Academy ·

2024/02/27

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Adrian R. Parry-Jones, FRCP, PhD Host: Stuart Connolly, MD, FRCPC Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical

en

00:00:00

The Path Forward: What’s On the Horizon?

Global Neurology Academy ·

2024/02/27

Host: Manesh R. Patel, MD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

en

00:00:00

Providing Optimal Care for the Anticoagulated Patient...

Global Neurology Academy ·

2024/02/27

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Natalie Kreitzer, MD, MS Host: Adrian R. Parry-Jones, FRCP, PhD Host: Rhonda Cadena, MD, FNCS, FCCM Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how

en

00:00:00

Emerging Data in the Management of Acute Ischemic...

Global Neurology Academy ·

2024/02/27

Host: Valeria Caso, MD, PhD Host: Manesh R. Patel, MD Host: Mike Sharma, MD, MSc, FRCPC Host: Ashkan Shoamanesh, MD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care,

en

00:00:00

Implementation of the 2022 AHA/ASA Guideline for the...

Global Neurology Academy ·

2024/02/27

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Rhonda Cadena, MD, FNCS, FCCM Host: Adrian R. Parry-Jones, FRCP, PhD Host: Stuart Connolly, MD, FRCPC Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how

en

00:00:00

Preventing Ischemic Stroke in Today’s World

Global Neurology Academy ·

2024/02/27

Host: Mike Sharma, MD, MSc, FRCPC This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

en

00:00:00

The Frontier of Stroke Diagnosis (RapidAI): How Can...

Global Neurology Academy ·

2024/02/27

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Greg Albers, MD Host: Rhonda Cadena, MD, FNCS, FCCM Host: Adrian R. Parry-Jones, FRCP, PhD Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these

en

00:00:00

Emerging Data in the Management of Intracranial...

Global Neurology Academy ·

2024/02/27

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Stuart Connolly, MD, FRCPC Host: Rhonda Cadena, MD, FNCS, FCCM Host: Greg Albers, MD Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments

en

00:00:00

While Antiplatelets Are Good…They Aren’t for Everyone

Global Neurology Academy ·

2024/02/27

Host: Valeria Caso, MD, PhD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

en

00:00:00

Missed Opportunities in Multiple Sclerosis Care:...

Global Neurology Academy ·

2023/12/20

Host: Bianca Weinstock-Guttman, MD This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment

en

00:00:00

Advancements in MRI Technology: Improved Diagnosis...

Global Neurology Academy ·

2023/12/20

Host: Bianca Weinstock-Guttman, MD This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment

en

00:00:00

From Prescription to Personalization: An HCP’s Guide...

Global Neurology Academy ·

2023/12/20

Host: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including

en

00:00:00

What Do Clinicians Need To Know? Utilizing Clinically...

Global Neurology Academy ·

2023/12/20

Host: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including

en

00:00:00

The Role of S1P Receptor Agonists in MS: Strategies...

Global Neurology Academy ·

2023/12/20

Host: Bianca Weinstock-Guttman, MD This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment

en

00:00:00

Transforming MS Management

Global Neurology Academy ·

2023/12/20

Host: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC Host: Bianca Weinstock-Guttman, MD This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and

en

00:00:00

The Complexity of Early MS Diagnosis

Global Neurology Academy ·

2023/12/20

Host: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC Host: Bianca Weinstock-Guttman, MD This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and

en

00:00:00

Navigating the Diagnostic Maze: Strategies for...

Global Neurology Academy ·

2023/12/20

Host: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including

en

21 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事